EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model

Zonghu Song iD, Nobuyuki Murakoshi, Dongzhu Xu, Binyang Xi iD, Yoshiko Murakata, Kazuhiro Aonuma, Kazuko Tajiri iD, Tomoko Ishizu

International Journal of Molecular Sciences · 24.10.2025 · 26 (21) · 10363

DOI: 10.3390/ijms262110363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.10.2025. Verfasst von Zonghu Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan. Hauptthemen laut MEDLINE: Triazoles, Azepines, Atrial Fibrillation, Calcium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C), Support for Pioneering Research Initiated by the Next Generation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bromodomain and extraterminal domain (BET) proteins act as epigenetic regulators of gene transcription. BET inhibitors have shown therapeutic potential in various models of heart failure; however, their efficacy in atrial fibrillation (AF) remains incompletely understood. This study investigated the effects of the BET inhibitor JQ1 in a mice model of AF. Wild-type male C57BL/6 mice were randomized into four groups: control, JQ1 alone (50 mg/kg, intraperitoneal), angiotensin II (AngII; 1 μg/kg/min), and AngII plus JQ1. After 2 weeks, electrophysiological studies revealed that JQ1 significantly reduced AngII-induced AF inducibility and duration. It also attenuated left atrial enlargement, diastolic dysfunction, and cardiac fibrosis. Molecular analyses indicated that JQ1 suppressed the AngII-induced upregulation of pro-fibrotic genes and restored Sirt1 expression. Moreover, JQ1 also inhibited AngII-enhanced oxidized CaMKII and phosphorylated RyR2 levels. In HL-1 atrial cardiomyocytes, JQ1 improved calcium handling abnormalities, shortened prolonged action potential duration (APD), and restored mitochondrial respiration and adenosine triphosphate (ATP) production, all of which had been impaired by AngII. These findings suggest that BET inhibition by JQ1 mitigates structural and electrical remodeling associated with AF by attenuating atrial fibrosis, and by restoring calcium homeostasis, mitochondrial function, and Sirt1 expression. JQ1 may represent a novel therapeutic strategy for the prevention and treatment of AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesAzepinesAtrial FibrillationCalciumMitochondriaAnimalsMiceMaleFibrosisDisease Models, AnimalHomeostasisMice, Inbred C57BLMyocytes, CardiacAngiotensin IISirtuin 1

Stichwörter der Autor:innen

BET proteinsJQ1Sirt1angiotensin IIatrial fibrillationbromodomaincalcium homeostasisfibrosismitochondrial respiration

Substanzen

Triazoles(+)-JQ1 compoundAzepinesCalciumAngiotensin IISirtuin 1

Autor:innen und Institutionen

  • Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
  • Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
  • Life Science Innovation, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
  • Krannert Cardiovascular Research Center, Indiana University School of Medicine, 1801 North Senate Boulevard, Indianapolis, IN 46202, USA.
  • Department of Cardiology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Chiba, Japan.

ORCID-Profile: Zonghu Song, Binyang Xi, Kazuko Tajiri

Förderung

  • Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C)
  • Support for Pioneering Research Initiated by the Next Generation

Zitieren

APA

Song, Z., Murakoshi, N., Xu, D., Xi, B., Murakata, Y., Aonuma, K., Tajiri, K., & Ishizu, T. (2025). BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model. International Journal of Molecular Sciences, 26(21), 10363. https://doi.org/10.3390/ijms262110363

Vancouver

Song Z, Murakoshi N, Xu D, Xi B, Murakata Y, Aonuma K, et al. BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model. International Journal of Molecular Sciences. 2025;26(21):10363. doi:10.3390/ijms262110363

BibTeX
@article{Song2025,
  author = {Song, Zonghu and Murakoshi, Nobuyuki and Xu, Dongzhu and Xi, Binyang and Murakata, Yoshiko and Aonuma, Kazuhiro and Tajiri, Kazuko and Ishizu, Tomoko},
  title = {BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10363},
  doi = {10.3390/ijms262110363}
}
Kostenlos starten →